LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients

SEOUL, South Korea & CAMBRIDGE, Mass — (BUSINESS WIRE) — LG Chem announced topline results for the phase 2 study evaluating the efficacy and safety profiles of LC350189, a novel non-pu…